The Orphan Drug Act of 1983 incentivized the pharmaceutical industry to develop drugs for rare diseases, which are now among the highest-priced drugs on the market. Specialty pharmacists can optimize treatment by providing proactive, holistic management that can improve outcomes and lower costs, according to pharmacist Brandeis Seymore.
Specialty pharmacists optimize rare disease treatment
Sign up for Specialty Pharmacy SmartBrief
News affecting the specialty pharmacy industry
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.